Target oncology teams Epiphany Partners provides oncology data and forecasting support to pharmaceutical, biotech, forecasting, HEOR, market research, and commercial teams. Sales opportunities exist in expanding to additional oncology-focused clients and cross-functional teams within existing customers seeking deeper data integration or customized epidemiology datasets.

Global data expansion EpiOncology offers datasets across 42+ countries and 110+ cancer sites, subtypes, biomarkers, and disease stages. Upsell opportunities include premium geographic coverage, expanded biomarker panels, or deeper stratification for late-stage trials and market access analytics in regions with growing oncology investment.

Decision support value The platform is positioned to improve speed and clarity of oncology decision-making for strategic planning and market evaluation. Sales focus could target firms prioritizing rapid forecasting, scenario planning, and cross-functional alignment to accelerate drug development pipelines.

Tech-enabled offerings Utilize the existing tech stack and data delivery capabilities to propose integrated solutions such as API access, custom dashboards, or automated reporting for clients with ongoing epidemiology needs, enabling scalable, recurring revenue through subscriptions or managed services.

Emerging partner ecosystem Current client landscape includes pharma, biotech, forecasting, HEOR, and market research partners. There is room to expand into adjacent services like patient flow modeling, competitive benchmarking, and cross-market epidemiology analytics, leveraging Epiphany’s deep domain expertise.